Anne Louise Töllböll Sörensen

7PUBLICATIONS
35CO-AUTHORS
Gene and molecular therapyCardiovascular medicine and haematology not elsewhere classifiedGlycoconjugatesHaematological tumoursNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 17, 2026
Improved survival with fludarabine-based therapies in mixed phenotype acute leukaemia: A population-based study using the WHO 2022 classification.

|Dec 22, 2025
Acquired von Willebrand Syndrome: A Comprehensive Review and a Nordic Perspective.

Eva Zetterberg, Karin Strandberg, Andreas Hillarp

|Dec 17, 2025
The glycosaminoglycan oncofetal chondroitin sulfate is a novel target for antibody-drug conjugate therapy for AML.

Joana Mujollari, Montserrat Estruch, Priya Khadgawat

|Jul 25, 2023
Venetoclax-based therapy for relapsed or refractory acute myeloid leukaemia following intensive induction chemotherapy.

Daniel Tuyet Kristensen, Rasmus Froberg Brøndum, Andreas Due Ørskov

|Jun 24, 2022
Blastic plasmacytoid dendritic cell neoplasm and cerebral toxoplasmosis: a case report.

Anna Maria Florescu, Anne Louise Tølbøll Sørensen, Henrik Vedel Nielsen

|Jun 17, 2021
A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2.

Anne Louise Tølbøll Sørensen, Magalie Rolland, Jacob Hartmann

Pageof 2

Frequent Collaborators

3 joint publications

Daniel Tuyet Kristensen

3 joint publications

Kristen Grønbæk

2 joint publications

Lisa-Maj Christensen

1 joint publications

Jacob Hartmann